4 Results for "

(R)-Omeprazole

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "(R)-Omeprazole" in MCE Product Catalog:

Cat. No.: HY-129923
CAS No.: 161796-77-6
Target:  

Cytochrome P450

Research Areas:  

Neurological Disease

(R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19 .
loading...
    loading...
Cat. No.: HY-Z2667
CAS No.: 119141-89-8
Synonyms: (R)-Omeprazole; (+)-Omeprazole
(R)-Esomeprazole ((R)-Omeprazole; (+)-Omeprazole) is an orally active cytochrome P450 2C19, CYP3A4, and CYP2C9-related metabolic modulator. (R)-Esomeprazole can be used in studies of digestive system diseases and compound metabolic interactions .
loading...
    loading...
Cat. No.: HY-129923R
CAS No.: 161796-77-6
Target:  

HBV Reference Standards

Research Areas:  

Neurological Disease

(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19 .
loading...
    loading...
Cat. No.: HY-134338R
CAS No.: 1314008-27-9
Research Areas:  

Others

(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19 .
loading...
    loading...